Economic cost-utility analysis of stage-directed gastric cancer treatment.
Arfon Gethyn Morgan Tregellis PowellJennifer R WheatCatherine EleyDavid Brian Thomas RobinsonStuart A RobertsWyn Griffith LewisPublished in: BJS open (2022)
Potentially curative treatment that included gastrectomy improved OS four-fold compared with BSC and was cost-effective at national thresholds of readiness to pay per QALY.